Ascendis Pharma A/S (ASND): Price and Financial Metrics
Ascendis Pharma A/S (ASND)
Today's Latest Price: $136.97 USD
3.03 (-2.16%)
Updated Jul 10 4:00pm
Add ASND to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
ASND Stock Summary
- ASND's price/sales ratio is 442.27; that's higher than the P/S ratio of 99% of US stocks.
- Over the past twelve months, ASND has reported earnings growth of 593.37%, putting it ahead of 97.5% of US stocks in our set.
- As for revenue growth, note that ASND's revenue has grown 62% over the past 12 months; that beats the revenue growth of 91.48% of US companies in our set.
- Stocks that are quantitatively similar to ASND, based on their financial statements, market capitalization, and price volatility, are FATE, QURE, AUTL, ARNA, and CRNX.
- ASND's SEC filings can be seen here. And to visit Ascendis Pharma A's official web site, go to www.ascendispharma.com.
ASND Daily Price Range
ASND 52-Week Price Range
ASND Stock Price Chart Technical Analysis Charts
ASND Price/Volume Stats
| Current price | $136.97 | 52-week high | $158.93 |
| Prev. close | $140.00 | 52-week low | $90.06 |
| Day low | $135.51 | Volume | 275,078 |
| Day high | $143.12 | Avg. volume | 225,305 |
| 50-day MA | $143.41 | Dividend yield | N/A |
| 200-day MA | $126.16 | Market Cap | 6.57B |
Ascendis Pharma A/S (ASND) Company Bio
Ascendis Pharma A/S is applying its innovative TransCon technology, which combines the benefits of prodrug and sustained release technologies, to develop a pipeline of best-in-class therapeutics that address significant unmet medical needs. The company was founded in 2006 and is based in Hellerup, Denmark.
Loading social stream, please wait...